Clindamycin Hydrochloride/Metronidazole

盐酸克林霉素/甲硝唑

Report date: 2022/01/14 13:23:58

Base Information

Drug NameClindamycin Hydrochloride/Metronidazole
Drug Alias NameClindamycin Hydrochloride and Metronidazole Liniment克林霉素甲硝唑搽剂
ClassificationSmall molecules
Mechanisms of Action50S ribosomal subunit inhibitorsDNA synthesis inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsRosaceaFolliculitisDermatitis, Seborrheic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Clindamycin HydrochlorideMetronidazole
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsRosaceaFolliculitisDermatitis, Seborrheic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A